Rescue Everolimus Post Lung Transplantation is Not Associated With an Increased Incidence of CLAD or CLAD-Related Mortality

Everolimus (EVE) has been used as a calcineurin inhibitor (CNI) minimization/ elimination agent or to augment immunosuppression in lung transplant recipients (LTR) with CNI-induced nephrotoxicity or neurotoxicity. The long-term evidence for survival and progression to chronic lung allograft dysfunct...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivulich, Steven, Paraskeva, Miranda, Paul, Eldho, Kirkpatrick, Carl, Dooley, Michael, Snell, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942680/
https://www.ncbi.nlm.nih.gov/pubmed/36824294
http://dx.doi.org/10.3389/ti.2023.10581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942680/
https://www.ncbi.nlm.nih.gov/pubmed/36824294
http://dx.doi.org/10.3389/ti.2023.10581

Ejemplares similares